Cogent Biosciences
COGT
COGT
53 hedge funds and large institutions have $62.5M invested in Cogent Biosciences in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
16
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.48M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.13M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$438K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$326K |
| 5 |
Millennium Management
New York
|
+$317K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.39M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.06M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$420K |
| 4 |
Walleye Trading
New York
|
-$288K |
| 5 |
D.E. Shaw & Co
New York
|
-$242K |
